AdreView (Medi-Physics Inc.)


Welcome to the PulseAid listing for the AdreView drug offered from Medi-Physics Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Medi-Physics Inc.
NON-PROPRIETARY NAME: Iobenguane I-123
SUBSTANCE NAME: IOBENGUANE I-123
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-09-19
END MARKETING DATE: 0000-00-00


AdreView HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAdreView from Medi-Physics Inc.
LABELER NAME: Medi-Physics Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mCi/mL)
START MARKETING DATE: 2008-09-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17156-235_bf3ce582-7976-4708-be4d-4fb30c0336dd
PRODUCT NDC: 17156-235
APPLICATION NUMBER: NDA022290

Other IOBENGUANE I-123 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Medi-Physics Inc.AdreView